Antimicrobial susceptibilities and capsular types of invasive streptococcus pneurnoniae isolated in children in mexico city

Microbial Drug Resistance

Volumn 3, Issue 2, 1997, Pages 153-158

  Echániz Aviles, Gabriela ^a   Velázquez Meza, Ma Elena ^a   Carnalla Barajas, María Noemí ^a   Soto Noguerón, Araceli ^a   Solórzano Santos, Fortino ^b   Miravete, Adolfo Pérez ^c   Gatica Marquina, Rodolfo ^a   Di Fabio, José Luis ^d  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^b HOSPITAL DE PEDIATRÍA   (Mexico)

^c HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

^d PAN AMERICAN HEALTH ORGANIZATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CEFOTAXIME; CHLORAMPHENICOL; ERYTHROMYCIN; ETHYLHYDROCUPREINE; OXACILLIN; PENICILLIN DERIVATIVE; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL MEMBRANE; BACTERIUM CULTURE; BLOOD CULTURE; CHILD; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEXICO; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIN RESISTANCE; PREVALENCE; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

BACTERIA (MICROORGANISMS); STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0030912380     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.1997.3.153     Document Type: Article

References (16)

1. Appelbaum, P.C. 1992. Antimicrobial resistance in Streptococcus pneumoniae: An overview. Clin. Infect. Dis. 15:77-83.
2. Calderón, J.E., G. Echániz, C. Conde, R. Rivera, G. Barriga, F. Solórzano, and J. Hill. 1993. Resistencia y serotipificación de 83 cepas de Streptococcus pneumoniae aisladas de niños portadores asintomáticos y enfermos. Bol. Med. Hosp. Infant. Mex. 50:854-860.
3. Doern, G.V., A. Brueggemann, H. Preston, and A. Rauch. 1996. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: Results of a 30-center national surveillance study. Antimicrob. Agents Chemother. 40:1208-1213.
4. Gamez, E.J., F. Solórzano, J. Lopez, L. Alvarez, and F. Ramirez. 1991. Etiología de la meningo-encefalitis purulenta en pediatría. Implicaciones terapeuticas. Gac. Med. Mex. 127:315-320.
5. Guiscafré, G.H., M. García, A. Trejo, M. García, R. Hernández, and O. Muñóz. 1981. Frecuencia de Haemophilus influenzae y de Streptococcus pneumoniae resistente a penicilina en portadores sanos. Arch. Invest. Med. Mex. 12:141-151.
6. Linares, J., R. Pallares, T. Alonso, J.L. Perez, J. Ayats, F. Gudiol, P.F. Viladrich, and R. Martin. 1992. Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain (1979-1990). Clin. Infect. Dis. 15:99-105.
7. Muñóz, O., J. Cantú, J. Trejo, and H. Fierro. 1979. Meningoencefalitis purulenta. Gac. Med. Mex. 115:89-91.
8. Muñóz, R., T.J. Coffey, M. Daniels, C.G. Dawson, G. Laible, J. Casai, R. Hakenbeck, M. Jacob, J.M. Musser, and B.G. Spratt. 1991. Intercontinental spread of a multiresistant clone of serotype 23F Streptococcus pneumoniae. J. Infect. Dis. 164:302-306.
9. National Committee for Clinical Laboratory Standards. 1995. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: Approved Standard M7-A3, 3rd ed. National Committee for Clinical Laboratory Standards, Villanova, PA.
10. National Committee for Clinical Laboratory Standards. 1995. Performance Standards for Antimicrobial Disk Susceptibility Tests - Approved Standard. NCCLS document M2-A5. 5th ed. National Committee for Clinical Laboratory Standards, Villanova, PA.
11. Organización Panamericana de la Salud. 1992. Atención del niño con infección respiratoria aguda. Washington, D.C., OPS/OMS. HPM/AR/01-92.
12. PAHO/WHO. 1992. Development of a conjugated vaccine against Streptococcus pneumoniae. HDP/HDR-RDV/92.1.
13. Robbins, J.B., R. Austrian, C.J. Lee, S.C. Rastogi, G. Schiffman, J. Henricksen, P.H. Makela, C.V. Broome, R.R. Facklam, R.H. Tiesjema, and J.C. Parke Jr. 1983. Considerations for formulating the second generation pneumococcal capsular polysaccharide vaccine with emphasis on cross-reactive types within groups. J. Infect. Dis. 148:1136-1159.
14. Sistema National de Evaluación. 1994. Tercera Vigilancia de los Progresos en la Aplicación de las Estrategias de Salud para Todos en el Año 2000, SPT/2000, INEGI/DGEIE, México, D.F.15.
15. Sniadack, D.H., B. Schwartz, H. Lipman, J. Bogaerts, J.C. Butler, R. Dagan, G. Echaniz-Aviles, N. Lloyd-Evans, A. Fenoll, N.I. Girgis, J. Henrichsen, K. Klugman, D. Lehmann, A.K. Takala, J. Vanderpitte, S. Gove, and R.F. Breiman. 1995. Po-tential interventions for the prevention of childhood pneumonia: geographic and temporal differences in serotype and serogroup distribution of sterile site pneumococcal isolates from children - implications for vaccine strategies. Pediatr. Infect. Dis. J. 14:503-510.
16. Wüst, J., E. Huf, and F.H. Kayser. 1995. Antimicrobial susceptibilities and serotypes of invasive Streptococcus pneumoniae strains in Switzerland. J. Clin. Microbiol. 33:3159-3163.